Molecular Testing Labs is a mission-driven, innovative health sciences company specializing in precision laboratory diagnostics. Molecular is committed to revolutionizing accessibility to testing via proprietary technology systems, advanced logistics, and cutting-edge research and development. We are pioneering and innovating distinctive distribution and specimen collection methods that open access to medical testing where geographic, financial, and stigma barriers once created gaps in the healthcare industry. We provide accessible and innovative laboratory solutions through collaborative partnerships with payors, private healthcare institutions, universities, commercial partners, and public health organizations. Molecular Testing Labs is a CLIA and CAP accredited, state-of-the-art, esoteric and reference laboratory. We specialize in high-complexity, molecular testing with an extensive portfolio of services including infectious disease, toxicology, targeted sequencing, single nucleotide polymorphism (SNP) genotyping, and Next-Generation Sequencing (NGS), and high-resolution immune profiling. Molecular Testing Labs offers a variety of clinical trial services comprising of assay development, trial site training, investigator support, and customized reporting. We apply the maximum level of control to obtain the most consistent and highest quality results. Molecular Testing Labs is founded on three guiding principles – Compliance, Innovation and Partnership. For more information, please visit our corporate website – www.moleculartestinglabs.com.